Batis et al. [15] found that the most common barriers to insulin in Saudi T2D patients are fear of needle injections, fear of hypoglycemia, weight gain, difficult administration technique, and social stigma or embarrassment. This evidence concerns the gene INS and type 2 diabetes mellitus.